76 related articles for article (PubMed ID: 632594)
21. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
[TBL] [Abstract][Full Text] [Related]
22. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.
Suzuki Y; Conley FK; Remington JS
J Immunol; 1989 Sep; 143(6):2045-50. PubMed ID: 2506275
[TBL] [Abstract][Full Text] [Related]
23. In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii.
Sharma SD; Hofflin JM; Remington JS
J Immunol; 1985 Dec; 135(6):4160-3. PubMed ID: 3877764
[TBL] [Abstract][Full Text] [Related]
24. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii.
Suzuki Y; Yang Q; Remington JS
J Parasitol; 1995 Dec; 81(6):1032-4. PubMed ID: 8544050
[TBL] [Abstract][Full Text] [Related]
25. Monocytes/macrophages infected with Toxoplasma gondii do not increase co-stimulatory molecules while maintaining their migratory ability.
Seipel D; Ribeiro-Gomes FL; Barcelos MW; Ramalho AV; Kanashiro MM; Kipnis TL; Arnholdt AC
APMIS; 2009 Sep; 117(9):672-80. PubMed ID: 19703127
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
Xue M; He S; Cui Y; Yao Y; Wang H
Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
[TBL] [Abstract][Full Text] [Related]
27. Toxoplasma gondii: effect of sublethal irradiation on host resistance in mice.
Johnson LL; Gibson GW; Sayles PC
Exp Parasitol; 1995 Sep; 81(2):172-81. PubMed ID: 7556559
[TBL] [Abstract][Full Text] [Related]
28. ES-62 is unable to modulate Toxoplasma gondii-driven Th1 responses and pathology.
Couper KN; Chen W; Houston KM; Harnett W; Johnson LL
Parasite Immunol; 2005 Apr; 27(4):147-50. PubMed ID: 15910423
[TBL] [Abstract][Full Text] [Related]
29. Maternal-fetal transmission of Toxoplasma gondii in interferon-gamma deficient pregnant mice.
Shiono Y; Mun HS; He N; Nakazaki Y; Fang H; Furuya M; Aosai F; Yano A
Parasitol Int; 2007 Jun; 56(2):141-8. PubMed ID: 17307382
[TBL] [Abstract][Full Text] [Related]
30. Toxoplasma gondii: lymphocyte function during acute infection in mice.
McLeod R; Van Le L; Remington JS
Exp Parasitol; 1982 Aug; 54(1):55-63. PubMed ID: 6980139
[No Abstract] [Full Text] [Related]
31. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. III. Suppression of antibody responses to parasite itself.
Suzuki Y; Joh K; Kobayashi A
Cell Immunol; 1987 Dec; 110(2):218-25. PubMed ID: 3690676
[TBL] [Abstract][Full Text] [Related]
32. Migratory responses of leukocytes infected with Toxoplasma gondii.
Lambert H; Dellacasa-Lindberg I; Barragan A
Microbes Infect; 2011 Jan; 13(1):96-102. PubMed ID: 20951223
[TBL] [Abstract][Full Text] [Related]
33. Macrophage proliferation and activation during Toxoplasma gondii infection in mice: relationship to lymphocyte stimulation.
Reikvam A
Acta Pathol Microbiol Scand C; 1976 Apr; 84(2):124-30. PubMed ID: 1266631
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to immune response gene products inhibit the IgM and IgG antibody response but not the development of resistance to Toxoplasma gondii.
Sharma SD; Shepard D; Remington JS
Cell Immunol; 1986 Apr; 98(2):323-32. PubMed ID: 3489548
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. I. Inhibition of proliferation of lymphocytes in primary antibody responses.
Suzuki Y; Kobayashi A
Cell Immunol; 1984 May; 85(2):417-27. PubMed ID: 6325025
[TBL] [Abstract][Full Text] [Related]
36. Inhibition or killing of an intracellular pathogen by activated macrophages is abrogated by TLCK or aminophylline.
McLeod R; Remington JS
Immunology; 1980 Apr; 39(4):599-605. PubMed ID: 7380481
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effect of intralesional injection with formalin-fixed Toxoplasma gondii organisms on Lewis lung carcinoma in Toxoplasma-infected mice.
Suzuki Y; Kobayashi A
Cancer Lett; 1985 Jan; 25(3):247-54. PubMed ID: 3971344
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte functions in acute & chronic murine toxoplasmosis.
Goyal M; Ganguly NK; Mahajan RC
Indian J Med Res; 1986 May; 83():487-94. PubMed ID: 3488272
[No Abstract] [Full Text] [Related]
39. Age-dependent differences in outcome of infections, with special reference to experiments in mice.
Louria DB; Sen P; Buse M
J Am Geriatr Soc; 1982 Dec; 30(12):769-73. PubMed ID: 6982911
[TBL] [Abstract][Full Text] [Related]
40. Studies on the regulation of lymphocyte reactivity by normal and activated macrophages.
Wing EJ; Remington JS
Cell Immunol; 1977 Apr; 30(1):108-21. PubMed ID: 67900
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
